Tenet Healthcare Corp.’s
(THC) fourth-quarter loss narrowed as the hospital
operator saw improved results amid higher prices.
The company also projected a 2009 loss bigger than expectations,
, according to
Thomson Reuters. Revenue is seen rising to
$9 billion to $9.2 billion
, in line
with estimates, with admissions growth of as much as 1%. Last year’s admissions
increase was 1.2%.
Tenet, which has been struggling to gain its footing after Read the rest of this entry »
(Adds analyst reaction beginning in seventh paragraph and updated stock
price.)
Eli Lilly & Co.
(LLY) expects to swing to a profit in
2009 from an anticipated loss in 2008 but sees sales growth slowing due to less
favorable currency exchange rates as well as generic competition for one of its
cancer drugs.
$6.5 billion
acquisition of ImClone Systems would result in a large charge for the fourth
quarter, causing the full-year net loss. The Read the rest of this entry »
Glaxo CEO Sees ‘Sustainable Growth’ From Deals, Drugs (Update1)
Jan. 9 (Bloomberg) –
, Europe’s largest
drugmaker, will boost its reliance on acquisitions and licensing
deals to bring new medicines to the market, Chief Executive
Officer Andrew Witty said in an interview.
The London-based company has 30 drugs in the final stage of
testing needed before approval and plans to release about five
new products a year, Witty, 44, said yesterday. Read the rest of this entry »
NEW DELHI: The Union health ministry
has come to the defence of Ranbaxy, alleging that vested interests were behind
the US ban on 30 drugs of the Indian pharma major. The US Food and Drug
Administration (FDA) was being pressurised by political and pharma lobbies to
act against Ranbaxy, a top official of the ministry said.
“The
FDA never had problems with the same drugs earlier. The moment the House (US
Congress) committee on trade, commerce Read the rest of this entry »
Glaxo CEO Sees ‘Sustainable Growth’ From Deals, Drugs (Update2)
Jan. 9 (Bloomberg) –
, Europe’s largest
drugmaker, will boost its reliance on acquisitions and licensing
deals to bring new medicines to the market, Chief Executive
Officer Andrew Witty said in an interview.
The London-based company has 30 drugs in the final stage of
testing needed before approval and plans to release about five
new products a year, Witty, 44, said yesterday. Read the rest of this entry »
KENILWORTH, N.J. -(Dow Jones)-
Schering-Plough Corp.
(SGP) plans to file for
regulatory approval of five new drugs in 2009, the drug maker’s executives said
Monday.
The company will file for regulatory green lights for the fertility drug
Corifollitropin alfa; a contraceptive called Nomac/E2; anti-HIV drug Vicriviroc;
a combination of allergy drugs mometasone and formoterol; and a new version of
implantable birth-control Implanon.
sells a version Read the rest of this entry »
BALTIMORE – The Baltimore City Health Department has issued a flu alert for across the region.
Health Department Commissioner Dr. Joshua Sharfstein said the city has seen an increase in patients testing positive for influenza in the last two weeks, including at Sinai Hospital.
“Probably for the next two months we’ll continue to see the flu. We’ve been seeing it since November. So yeah, we see a lot,” said Sinai Hospital nurse Jere Waddy.
One Read the rest of this entry »
In an economic downturn, some people are dealing with the pressure by upping their exercise routine and setting new fitness goals. Glendale resident Lisa Olona, owner of Northwest Valley Adventure Boot Camp, runs a variety of four-week fitness programs spanning Glendale and Peoria. She said she has seen an uptick in enrollment from those coping with new financial or professional pressures and looking to unwind.
“(Exercise) helps motivate people, Read the rest of this entry »
WellPoint Sees Easing of Medical Inflation, Sparking Insurers
Jan. 28 (Bloomberg) — Health insurers gained as industry
leader
reported a smaller increase in medical
costs than analysts expected for the fourth quarter, a sign the
recession may keep expenses in check this year.
WellPoint, which covers one in nine Americans, said its
medical expenses increased less than 8 percent in the quarter, at
the low end of a forecast given in October. The Read the rest of this entry »
Thomson Reuters is the world’s largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of Read the rest of this entry »